5% of Covaxin royalty to ICMR raises questions, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Bharat Biotech will pay a royalty of 5% on the net sales of Covaxin, its Covid-19 vaccine, to Indian Council of Medical Research (ICMR).This has prompted public health and intellectual property experts to voice concerns., Bharat Biotech will pay a royalty of 5% on the net sales of Covaxin, its Covid-19 vaccine, to Indian Council of Medical Research (ICMR).This has prompted public health and intellectual property experts to voice concerns., , Read More